CAC
PBMWW

Cowen and Company’s Psyence Biomedical Warrant PBMWW Stock Holding History

Cowen and Company’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,220,986
Closed -$15.4K – 321
2024
Q3 		$15.4K Buy
1,220,986
+51,780
+4% +$906 ﹤0.01% 459
2024
Q2 		$12.3K Buy
1,169,206
+1,038,919
+797% +$57.8K ﹤0.01% 440
2024
Q1 		$9.12K Buy
+130,287
New +$8.12K ﹤0.01% 517

Other funds holding PBMWW

HCI
Harraden Circle Investments New York $499M AUM 24.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Cowen and Company's PBMWW Position: Q4 2024 in Review

Cowen and Company sold out of Psyence Biomedical Warrant (PBMWW) in Q4 2024, closing a stake of 1,220,986 shares — an estimated $15.4K sold.

Cowen and Company first reported a position in PBMWW in Q1 2024 and held it in 3 quarters. The position peaked at $15.4K in Q3 2024. 22 funds tracked by Wall St. Rank hold PBMWW as of Q4 2024.

  • Cowen and Company reported no remaining Psyence Biomedical Warrant position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 1,220,986 Psyence Biomedical Warrant shares in Q4 2024, an estimated $15.4K.
  • Cowen and Company first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 3 quarters.
  • Cowen and Company's Psyence Biomedical Warrant position peaked at $15.4K in Q3 2024.
  • 22 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.